Health Care & Life Sciences » Biotechnology | Titan Biotech Ltd.

Titan Biotech Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
391,213.00
403,151.50
457,587.20
527,381.40
587,278.00
Cost of Goods Sold (COGS) incl. D&A
333,850.60
336,687.10
381,561.00
438,746.40
472,058.00
Gross Income
57,362.40
66,464.40
76,026.20
88,635.00
115,220.00
SG&A Expense
33,332.40
34,584.10
42,667.00
41,977.50
53,596.00
EBIT
23,609.50
30,987.80
30,904.50
45,643.40
61,624.00
Unusual Expense
1,145.90
548.60
-
-
-
Non Operating Income/Expense
3,817.50
3,984.10
5,479.70
2,600.70
4,762.00
Interest Expense
3,943.30
9,922.90
9,872.00
14,757.50
23,893.00
Pretax Income
22,337.90
24,500.50
26,512.20
33,486.60
42,493.00
Income Tax
7,419.90
8,181.20
8,830.60
11,678.30
11,417.00
Consolidated Net Income
14,917.90
16,319.30
17,681.60
21,808.20
31,076.00
Net Income
14,917.90
16,319.30
17,681.60
21,808.20
31,076.00
Net Income After Extraordinaries
14,917.90
16,319.30
17,681.60
21,808.20
31,076.00
Net Income Available to Common
14,917.90
16,319.30
17,681.60
21,808.20
31,076.00
EPS (Basic)
2.12
2.11
2.28
2.82
4.02
Basic Shares Outstanding
7,038.70
7,738.70
7,738.70
7,738.70
-
EPS (Diluted)
2.12
2.11
2.28
2.82
-
Diluted Shares Outstanding
7,038.70
7,738.70
7,738.70
7,738.70
-
EBITDA
31,884.70
39,452.40
38,711.20
53,930.40
70,943.00
Other Operating Expense
420.50
892.60
2,454.70
1,014.10
-

About Titan Biotech

View Profile
Address
903-909, Bigjos Tower
New Delhi Delhi 110034
India
Employees -
Website http://www.titanbiotechltd.com
Updated 09/14/2018
Titan Biotech Ltd. engages in manufacturing of peptone, extract, and chemicals, and trading of handicap goods. Its products include pharmaceuticals and nutraceuticals, food additives, agro nutrients, biotechnology and fermentation, cosmetic ingredients, veterinary and animal feed ingredients, laboratory chemicals, and victory ingredient. The company was founded on February 18, 1992 and is headquartered in Delhi, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.